Main Services:
Offer agile, comprehensive end-to-end CDMO solutions that optimize time and cost efficiencies for biopharma companies around the world. Leverage global CDMO capabilities, state-of-the-art, FDA-registered facility in the U.S., with deep expertise in biologics Devl/MFG. Specialize in a diverse range of biologics, including mAbs, bi-specifics, fusion proteins, recombinant proteins, and enzymes. From cell line development to commercial manufacturing, we bring extensive global and regional regulatory affairs expertise to ensure compliance and success at every stage of the process.
+FDA Registered +130,000 sf GMP and R&D space +14,000 sf temperature controlled GMP warehouse +Single-Use Bioreactors (SUBs): 2 x 50L, 2 x 250L, 4 x 1000L , 2 x 2000L (in plan) +Stainless Steel Fermentors: 1 x 150L, 1 x 300L (SUF) +3 GMP suites
+70+ cGMP batches with 100% success rate continuously since 2014 +48,000 sf of GMP and R&D space +cGMP, ICH, FDA, EMA, TFDA, PIC/S +Single-Use Bioreactors (SUBs): 2 x 50L, 4 x 500L (2 in plan)
Business Interests
CDMO, Co-Development
Contact Info
Rose Chen
Director, Business and Program Management
+886 3-658-3899 #209
rose.chen@borabiologics.com